1697. Dose-response Studies of the Novel Bacterial Leucyl-tRNA Synthetase Inhibitor, Epetraborole, in the Intracellular Hollow Fiber System Model of Mycobacterium avium complex Lung Disease

BACKGROUND: Based on meta-analyses the current standard-of-care regimen (SOC) for Mycobacterium avium complex (MAC) lung disease achieves a sustained sputum conversion rate of ∼54% at best. Epetraborole (EBO) is a boron-containing oral inhibitor of bacterial leucyl-tRNA synthetase, an essential enzy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapagain, Moti, Athale, Shruti, Pasipanodya, Jotam, Howe, David, Alley, M R K, Gumbo, Tawanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752474/
http://dx.doi.org/10.1093/ofid/ofac492.1327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752474/
http://dx.doi.org/10.1093/ofid/ofac492.1327

Ejemplares similares